Clinical trial
A Prospective, Multi-Center, Non-randomized, Single Arm, Open Label, Study to Evaluate the Safety and Effectiveness of the Biosensors Microcatheter in Coronary Chronic Total Occlusions (CTO) - BIOMICS
NCT04966273 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Non-randomized, Single Arm, Open Label, Study to Evaluate the Safety and Effectiveness of the Biosensors Microcatheter in Coronary Chronic Total Occlusions (CTO) - BIOMICS
- Lead sponsor
- Biosensors Europe SA
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 18, 2022
- Completion date
- January 3, 2023
- Enrollment
- 101 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic heart disease